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Background: Radiation pneumonitis (RP) and organizing pneumonia (OP) are the two main types of lung damage
that can occur after lung irradiation. The goal of this study was to evaluate the relationship between RP and OP
after irradiation for breast cancer.
Methods: Four hundred and twenty-eight patients who underwent radiotherapy for breast cancer were identified.
The whole breast was irradiated with two tangential photon beams. Chest computed tomography (CT) scan were
performed when patients showed any symptoms that were suspicious for pneumonitis.
Results: Five patients (1.2%) were diagnosed with OP. All five patients showed ground glass opacities and
consolidation of the border of the lesion of RP in the radiation fields. Infiltration of OP spread from the site of RP to
the hilum of the ipsilateral lung. Between RP and OP, a free region space (FRS) could be detected.
Conclusions: OP is closely related to RP. All OP lesions developed near the site of RP.
Keywords: Organizing pneumonia (OP), Breast cancer, Radiation pneumonitis (RP)Background
Postoperative radiotherapy plays an important role in
the management of breast cancer and can reduce the
local and regional recurrence, thereby improving out-
comes [1,2]. One study reported that the overall fre-
quency of Grade 2 or 3 adverse events after radiotherapy
was 3.8% in Japanese women with breast cancer [3].
Adverse events following irradiation for breast cancer
include pain and pigmentation of the chest wall, skin
ulcerations, soft tissue fibrosis, rib fractures, myocar-
dial infarction, pericardial effusion, and symptomatic
or asymptomatic lung damage. Pneumonitis is one
type of radiation-induced lung damage, and it can be
divided into two types: radiation pneumonitis (RP) and
organizing pneumonia (OP) [4]. OP is included RP in
the broad sense, but OP in this paper is defined OP
without RP.* Correspondence: yumi-oie@fujita-hu.ac.jp
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reproduction in any medium, provided the orRP is a form of acute or subacute lung damage related
to the dose of radiation. It develops along the irradiated
fields and results in pulmonary fibrosis. Asymptomatic
RP is commonly observed, while symptomatic RP is rare.
Past study reported majority (74%) of patients with RP
were asymptomatic [5]. OP is a form of subacute lung
damage that occurs independent of the radiation dose.
It is identified inside and outside of the tangential irra-
diated field and does not result in pulmonary fibrosis.
Although OP is rare, when it does occur, it is usually
found in symptomatic. RP and OP are suspected to
belong in another etiological category. The goal of the
present study is to investigate the relationship between
RP and OP.Methods
Between January 2002 and December 2009, 428 patients
with breast cancer underwent radiotherapy at Fujita Health
University in Japan. Patients undergoing breast-conserving
surgery, total mastectomy, or no surgery were included.
Patients with recurrent breast cancer and patients who. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 2 Radiation therapy details
Whole-breast irradiation / Chest wall irradiation 400/34
50 Gy in 25 fractions 433
54 Gy in 27 fractions 1
Irradiation to the regional lymph nodes (yes/no) 45/388
supraclavicular region of affected side
50 Gy in 25 fractions 26
40 Gy in 20 fractions 5
supraclavicular and parasternal region of affected side
50 Gy in 25 fractions 4
45 Gy in 23 fractions 1
40 Gy in 20 fractions 8
supraclavicular and parasternal region of bilateral side
40 Gy in 20 fractions 1
Boost to tumor bed (yes/no) 31/403
9 Gy in 3 fractions 30
6 Gy in 3 fractions 1
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patient with bilateral breast cancer treated with radiother-
apy at separate times was counted as two cases. Six pa-
tients with bilateral breast cancer who were treated with
radiotherapy to both breasts simultaneously were counted
as six patients and 12 breasts. Thus, the total number of
patients treated with irradiation was 428, and the total
number of irradiated breasts was 434.
Patients were asked to follow-up at the hospital after
radiotherapy. When respiratory symptoms and/or gen-
eral symptoms appeared, computed tomography (CT)
was performed. The diagnosis of OP was based on the
criteria proposed by Crestani et al. [4]: (1) radiation to
the breast within 12 months, (2) general and/or respira-
tory symptoms lasting for 2 weeks; (3) radiographic lung
infiltration outside the radiation port; and (4) no evi-
dence of specific cause.
Characteristics of the 428 patients are shown Table 1.
All patients were women. The median age was 56 years.
Collagen vascular disease was found in four patients, in-
cluding two patients with rheumatoid arthritis, one pa-
tient with systemic lupus erythematosus (SLE), and one
patient with polymyositis. Allergic disease was found in
20 patients, including 15 patients with asthma, and fiveTable 1 Patient characteristics (n = 428)
Age (y)
20 ~ 29 3
30 ~ 39 35
40 ~ 49 104
50 ~ 59 117
60 ~ 69 124
70 ~ 79 41
80 ~ 89 4
Irradiated breast (right/left/bilateral) 211/208/9
Collagen vascular disease (yes/no) 4/424
Allergy disease (yes/no) 20/408
Lung disease (yes/no) 2/426
Diabetes (yes/no) 29/399









IV 1patients with atopic dermatitis. Lung disease was found
in two patients, including one patient with interstitial
pneumonia and another patient with tuberculosis. The
details of radiotherapy are shown in Table 2. Whole
breast irradiation and chest wall irradiation with two tan-
gential 4 MV photon beams was performed. For irradi-
ation of the regional lymph nodes, an anterior photon












Tamoxifen or Tremifen (yes/no) 157/271
Aromatase inhibitor(yes/no) 177/251
Trastuzumab(yes/no) 27/401
FEC-T = 5-fluorouracil, epirubicin, cyclophosphamide plus taxane.
AC-T = adriamycin, cyclophosphamide plus taxane.
FEC = 5-fluorouracil, epirubicin, cyclophosphamide.
AC = adriamycin, cyclophosphamide.
EC-T = epirubicin, cyclophosphamide plus taxane.
CMF = cyclophosphamide, methotrexate, 5-fluorouracil.
TC = docetaxel, cyclophosphamide.























1 66 Right FEC ― 229 Right upper• middle•
lower lobe
once No 385
2 52 Right FEC Tamoxifen 218 Right middle lobe once No 206
3 68 Right ― ― 229 Right middle lobe 5 times Yes 799
4 54 Right ― Anastrozole 168 Right middle lobe once Yes 244
5 55 Bilateral CMF Exemestane 170 Bilateral middle lobe ― No 38
median 55 218 244
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therapy are shown in Table 3. No patient was treated
with concurrent chemoradiation therapy.
Results
Five (1.2%) of the 428 patients were diagnosed with OP
(Table 4). All patients were diagnosed by clinical findings
and imaging findings. Transbronchial lung biopsy (TBLB)
was performed for the diagnosis in three cases. OP was re-
vealed in two patients. In one patient, only non-specific
change was revealed by TBLB specimens. Infection was
ruled out in all five patients. All five patients were non-
smokers, and none of these five patients had a history of
allergic disease, collagen vascular disease, lung disease, or
diabetes. Ages of these five patients were 52, 54, 55, 66, 68
years (median, 55 years old). Four of the five patients had
right breast cancer, and one had bilateral breast cancer.Figure 1 Fusion of CT images at the time of diagnosis of OP and trea
D = patient 4, E = patient 5). There were free regions between the radiatiThus, there were six affected breasts in total. Clinical
staging by the tumor-node-metastasis classification
system showed that four breasts were T1N0M0 and
that one breast was T2N0M0. All five patients had
undergone breast-conserving surgery. For whole-breast
irradiation, all breasts received 50 Gy in 25 fractions.
The photon energy was 4 MV in all five patients.
None of the five patients underwent irradiation to the
regional lymph nodes (including the supraclavicular
region, parasternal region or axillary region) or boost
irradiation to the tumor bed. The percent of V20Gy
compared with whole lung volume of each five pa-
tients was under 15%. Three (60%) of the five patients
received chemotherapy before radiotherapy. Two (40%)
of the five patients received concurrent endocrine
therapy (tamoxifen and aromatase inhibitor, respect-
ively). No patients received trastuzumab.tment planning images (A = patient 1, B = patient 2, C = patient 3,
on lesions and the radiation-induced OP (arrow).
Figure 2 Close-up schema of the relationship between RP
lesion and OP lesion.
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The interval from completion of radiotherapy to occur-
rence of symptoms ranged from 170 to 229 days (median,
218 days). The initial clinical symptoms in the five pa-
tients were cough (four patients), fever (three patients),
chest pain (two patients), and general malaise (one pa-
tient). In all five patients, the initial abnormal pulmonary
findings were observed in the ipsilateral area, includingFigure 3 Fusion of CT images and %dose-depth curve. a. CT image at
decreased sharply at the tangential line. b. CT imaging at the diagnosis of
and FRS. The intersection (arrow) of the line with the %depth-dose curve is
closer to the chest wall because of lung volume reduction related to fibrot
moved to the border of RP. The FRS corresponds with the region of steepthe irradiated field. All patients were given steroids after
being diagnosed with OP. The duration of steroid ad-
ministration ranged from 38 days to 799 days (median,
244 days). Clinical and physiologic improvement and
normalization of the pulmonary opacities occurred rap-
idly in all five patients after steroid administration, but
relapse occurred in four patients during the steroid
taper (two patients) or soon after steroid withdrawal
(two patients). Five episodes of relapse occurred in one
patient. One episode of relapse occurred in three pa-
tients. Migration of consolidation and of ground-glass
opacities (GGO) was confirmed on CT examination in
all five patients. Abnormal pulmonary findings appeared
on the contralateral side in two of five patients at the
relapse time.
CT findings
All five patients showed GGO and consolidation of RP
in the radiation fields. Initial OP lesions were in close
proximity to the RP lesions, but the lesions were not
connected. Infiltration of OP spread from the site of RP
to the hilum of the ipsilateral lung. Between both le-
sions, there was a free region space (FRS) (Figures 1, 2).
FRS between the lesions of RP and OP were recognized
in all five patients.
Discussion
Radiation-induced lung injury can be divided into RP
and OP [4]. RP is different from OP in several ways:
(1) RP occurs during radiotherapy or shortly afterthe radiation treatment planning and %dose-depth curve. % Dose
OP and %dose-depth curve. The line (A) shows the border between RP
associated with a radiation dose > 20 Gy. The RP lesion might appear
ic change following RP. c. The 20 Gy point of the %dose-depth curve
change of distribution.
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within 1 year after completion of radiotherapy; (2) RP
lesions are characterized by alveolar opacities and are
limited to the irradiated area, while OP lesions are
characterized by lung infiltrates outside the radiation
field and frequently migrate; (3) RP occurs in almost all
patients whose lungs have been irradiation (i.e., not
only in breast cancer patients), while the incidence of
OP in patients with breast cancer or other malignancies
is low; (4)RP always results in fibrosis and never re-
lapses, while OP usually resolves without fibrosis but
commonly relapses when the glucocorticoid is with-
drawn. Further, OP lesions tend to migrate (i.e., the re-
lapsed lesions often occur in another area, or even
opposite side, relative to the initial lesions).
Imaging studies suggest that RP and OP may be re-
lated to one another. On CT scan, RP lesions occur close
to the thoracic wall, and most OP lesions develop in
close proximity to the RP lesions. RP occurs at site that
have been irradiated with a dose > 20 Gy. Ogo et al.
reported most OP lesions develop outside of the irradi-
ated field and few cases (2 of 37) show no relation with
RP [6]. OP shadows extend beyond the radiation port
and often migrate to another side of the lung when OP
relapsed. Although OP has been suggested to be an in-
direct effect of radiation, radiotherapy may play an im-
portant role in the development of OP [4]. OP is a form
of lung toxicity that likely arises between some inter-
action between radiotherapy and the immune system
[6], which may also explain the occurrence of OP lesions
outside the irradiated field.
It is an important question why OP occurs after radio-
therapy for breast cancer more frequently than after radio-
therapy for other malignancies. Lungs are often irradiated
for the treatment for malignancies. Late damage to the
lung, which usually manifests as fibrosis, is a radiation
dose-dependent occurrence in patients undergoing radio-
therapy for lung cancer, esophageal cancer and mediastinal
tumors. The incidence of OP after radiotherapy in pa-
tients with breast cancer is 1.8-2.9% [6-11]. In contrast,
RP occurs much more commonly after radiotherapy in
patients with lung cancer [12-14] or esophagus cancer
[15,16]. Several reports describe the occurrence of OP
after radiotherapy in patients with lung cancer [17-19].
The reasons why the incidence of OP is lower after
radiotherapy for lung cancer, esophageal cancer, and me-
diastinal tumor than after radiotherapy for breast cancer
remain unknown. One explanation could be related to
the fact that the dose distribution of radiotherapy for
breast cancers differs from that for other malignancies.
Further, tangential irradiation is used to treat breast can-
cer but not other malignancies.
The relationship between the irradiated field and RP
and OP is illustrated in Figure 2. The inner lines composedby the opposed tangential fields form a straight line, which
indicates a sharp decline in absorbed dose. Tangential ir-
radiation can reduce the volume of the irradiated lung
when compared with other irradiation methods, such as
opposing portal irradiation and single field irradiation.
%Dose-depth curves are shown relative to dose distri-
butions in Figure 3a. The tolerance dose of RP is about
20 Gy; the more V20Gy increases, the higher the inci-
dence of RP [12,20-22].
The border of the RP is closer to the thoracic wall
than the point of 20 Gy on the planning CT (Figure 3b).
This shift of the RP might actually be related to a de-
crease in lung volume because of fibrous changes after
RP. The dose distribution should be shifted to coincide
with the point of 20 Gy with the border of RP (Figure 3).
This shifted dose distribution is suspected to be the ac-
tual dose distribution on the CT at the onset of OP.
RP and OP are closely related to one another. How-
ever, between the lesions of RP and OP, FRS was
detected on the CT images. The same findings were seen
in a previous report [6]. Fusion of CT images at the on-
set of OP and the planned dose distributions of radio-
therapy is shown in Figure 3. FRS on the CT images was
located at the region next to the rapidly decreasing dose
area. The irradiated dose of FRS is suspected to occur
at < 20 Gy, but not at zero. This dose area from 0 to
20Gy may allow an immunologic reaction that results
in development of the initial OP point (or area).
The present study suggests that the OP lesions are
closely connected to the FRS detected on the CT im-
ages, which arise next to the rapidly decreasing dose
area. In conformal irradiation and intensity modulated
radiation therapy (IMRT), the dose contribution some-
times shows a steep dose gradient. Further pathology
studies are needed to investigate this hypothesis.
Conclusions
OP occurred in 1.2% of patients with breast cancer who
underwent radiotherapy. Most OP develops after irradi-
ation for breast cancer. A low dose region and a steep
dose gradient may be associated with the onset of the
OP lesion. This finding suggests that frequent and active
follow-up CT after radiotherapy may be needed.
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